• Citer

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.

par Davies, C;Godwin, J;Gray, Richard;Clarke, M.J.;Cutter, D;Darby, S;McGale, P;Pan, Huade;Taylor, C;Wang, Yiwei ;Dowsett, Mitch;Ingle, James N;Peto, R
Référence Lancet, 378, 9793, page (771-784)
Publication Publié, 2011-08

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
Auteur:	Davies, C; Godwin, J; Gray, Richard; Clarke, M.J.; Cutter, D; Darby, S; McGale, P; Pan, Huade; Taylor, C; Wang, Yiwei; Dowsett, Mitch; Ingle, James N; Peto, R
Informations sur la publication:	Lancet, 378, 9793, page (771-784)
Statut de publication:	Publié, 2011-08
Sujet CREF:	Cancérologie
MeSH keywords:	Antineoplastic Agents, Hormonal -- adverse effects -- therapeutic use
	Breast Neoplasms -- drug therapy -- metabolism -- mortality -- pathology
	Chemotherapy, Adjuvant
	Female
	Humans
	Neoplasm Recurrence, Local -- prevention & control
	Neoplasms, Second Primary -- chemically induced
	Randomized Controlled Trials as Topic
	Receptors, Estrogen -- metabolism
	Receptors, Progesterone -- metabolism
	Selective Estrogen Receptor Modulators -- adverse effects -- therapeutic use
	Tamoxifen -- adverse effects -- therapeutic use
Note générale:	Journal Article
	Meta-Analysis
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0140-6736
	info:doi/10.1016/S0140-6736(11)60993-8
	info:pii/S0140-6736(11)60993-8
	info:scp/80052262856
	info:pmid/21802721
	PMC3163848